Neurim Pharmaceuticals Ltd. is a drug discovery and development company.
Its first approved drug, Circadin® – prolonged release melatonin for insomnia is commercially available in Europe, Asia-Pacific and the Middle East.
Neurim Pharmaceuticals has a promising pipeline of New Chemical Entities effective in Central Nervous System disorders.
We focus on the diseases of aging, such as insomnia and neuro-degenerative diseases, with the goal of improving quality of life.
To establish a leadership position in small molecule drug research and development aimed at improving quality of life.